Search results
Results from the WOW.Com Content Network
In a chemical reaction, the half-life of a species is the time it takes for the concentration of that substance to fall to half of its initial value. In a first-order reaction the half-life of the reactant is ln(2)/λ, where λ (also denoted as k) is the reaction rate constant.
The biological half-lives "alpha half-life" and "beta half-life" of a substance measure how quickly a substance is distributed and eliminated. Physical optics: The intensity of electromagnetic radiation such as light or X-rays or gamma rays in an absorbent medium, follows an exponential decrease with distance into the absorbing medium.
Absorption half-life 1 h, elimination half-life 12 h. Biological half-life (elimination half-life, pharmacological half-life) is the time taken for concentration of a biological substance (such as a medication) to decrease from its maximum concentration (C max) to half of C max in the blood plasma.
The half-life, t 1/2, is the time taken for the activity of a given amount of a radioactive substance to decay to half of its initial value. The decay constant , λ " lambda ", the reciprocal of the mean lifetime (in s −1 ), sometimes referred to as simply decay rate .
Half-life has units of time, and the elimination rate constant has units of 1/time, e.g., per hour or per day. An equation can be used to forecast the concentration of a compound at any future time when the fractional degration rate and steady state concentration are known:
As an extreme example, the half-life of the isotope bismuth-209 is 2.01 × 10 19 years. The isotopes in beta-decay stable isobars that are also stable with regards to double beta decay with mass number A = 5, A = 8, 143 ≤ A ≤ 155, 160 ≤ A ≤ 162, and A ≥ 165 are theorized to undergo alpha decay.
The fluorine produced is in the form of a water solution of [18 F]fluoride, which is then used in a rapid chemical synthesis of various radio pharmaceuticals. The organic oxygen-18 pharmaceutical molecule is not made before the production of the radiopharmaceutical, as high energy protons destroy such molecules ( radiolysis ).
The three long-lived nuclides are uranium-238 (half-life 4.5 billion years), uranium-235 (half-life 700 million years) and thorium-232 (half-life 14 billion years). The fourth chain has no such long-lasting bottleneck nuclide near the top, so almost all of the nuclides in that chain have long since decayed down to just before the end: bismuth-209.